ELIZABETH MURRAY: Open Payments
NPI 1437860442 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,527 in 66 payments from 18 companies in 2025. Trend: 2023 $287 · 2024 $1,461 · 2025 $1,527
Food & beverage: $1,493Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $230 |
| GlaxoSmithKline, LLC. | 11 | $229 |
| Novartis Pharmaceuticals Corporation | 11 | $215 |
| Regeneron Healthcare Solutions, Inc. | 5 | $127 |
| BioCryst US Sales Co., LLC | 4 | $117 |
| Genentech USA, Inc. | 3 | $90 |
| GENZYME CORPORATION | 3 | $81 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $76 |
| CSL Behring | 2 | $70 |
| Organon LLC | 2 | $51 |
Products named: XOLAIR, DUPIXENT, NUCALA, FASENRA, ORLADEYO, NEFFY, Rhapsido, OPZELURA.
Industry payments across GA — which companies pay providers there.
